Potentially explanatory factors | |
---|---|
Quality of registration | |
% of episodes with a meaningful diagnosis, median (10–90%) | 96.9 (69.8–99.9) |
% of contacts linked to an episode, median (10–90%) | 96.5 (78.3–99.3) |
Collaboration | |
Participation in pharmacotherapy audit meetings (%) | |
Yes | 97.1 |
No | 2.9 |
Number of procedures with pharmacist (%) | |
0–5 topics | 18.4 |
6–8 topics | 45.6 |
9–10 topics | 35.9 |
Agreement with pharmacist on coprescribing laxative (%) | |
Yes | 80.6 |
No | 16.0 |
GP with an in-house pharmacy | 3.4 |
Use of an electronic clinical decision support system (%) | |
Always | 21.1 |
In half or more than half of all prescriptions | 18.7 |
In less than half of all prescriptions | 27.3 |
Never to hardly ever | 33.0 |
Familiar with guideline recommendations (%) | |
Yes | 99.5 |
No | 0.5 |
Agree with guideline recommendations (%) | |
Yes | 88.9 |
No | 11.1 |